Pharmabiz10 天
Glenmark Pharma introduces generic Xalatan ophthalmic solution, 0.005% in US
USA (Glenmark) announced the launch of latanoprost ophthalmic solution, 0.005% (0.05 mg/mL). Glenmark’s latanoprost ophthalmic solution, 0.005% (0.05 mg/mL) is bioequivalent and therapeutically ...